Brief: Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease

Kiniksa Pharmaceuticals International

09/07/2024 13:19

July 9 (Reuters) - Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA PHARMACEUTICALS COMMENCES ENROLLMENT IN ABIPRUBART
PHASE
2B CLINICAL TRIAL IN SJÖGREN’S DISEASE
    * KINIKSA PHARMACEUTICALS LTD - ABIPRUBART TRIAL IN
SJÖGREN'S
DISEASE FULLY FUNDED
    * KINIKSA PHARMACEUTICALS LTD - EXPECTS TO REMAIN CASH FLOW
POSITIVE ANNUALLY

Source text for Eikon:  ID:nGNX2J9JGv 
Further company coverage:  KNSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))